Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study

Saved in:
Bibliographic Details
Published inPediatric rheumatology online journal Vol. 13; no. Suppl 1; p. O58
Main Authors Aróstegui, JI, Anton, J, Calvo, I, Robles, A, Speziale, A, Joubert, Y, Junge, G, Yagüe, J
Format Journal Article
LanguageEnglish
Published BioMed Central Ltd 28.09.2015
BioMed Central
Subjects
Complications and side effects
Health aspects
Monoclonal antibodies
Oral Presentation
Online AccessGet full text

Cover

More Information
ISSN:1546-0096
1546-0096
DOI:10.1186/1546-0096-13-S1-O58